Tradestie Institutional Equity Comparison Engine

BIOT vs DSAC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DSAC Overall Edge

DSAC Captures Institutional Edge (1โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DSAC (DSAC) driven by superior Momentum & Technical. Fundamentally, BIOT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus DSAC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BIOT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DSAC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BIOT N/M vs DSAC N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner DSAC
1Y -98.8% vs +1.8% ยท 52W Pos 0% vs 50%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BIOT US Equity
BIOT
Institutional Equity
$0.19
-1.1% 1D
Market Cap N/A
1M Return -17.65%
1Y Return -98.79%
Forward P/E N/M
Unified AI Score
52.7 / 100 HOLD
Tech 52.0 Fund 69.0 Flow 50.0 Mom 50.0
DSAC US Equity
DSAC
Institutional Equity
$10.18
+0.39% 1D
Market Cap N/A
1M Return +0.3%
1Y Return +1.8%
Forward P/E N/M
Unified AI Score
57.0 / 100 HOLD
Tech 50.0 Fund 53.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BIOT -98.79% DSAC +1.8% Spread: +98.99 pp (DSAC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BIOT TTM Op. Margin: N/A DSAC TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIOT vs DSAC. Trailing 12-month operating profitability (BIOT N/A vs DSAC N/A) and valuation multiples (BIOT N/M vs DSAC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BIOT (0) vs DSAC (3)
Institutional Metric BIOT DSAC Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 0% ($0โ€“$50) 50% ($10โ€“$10) Stronger Trend DSAC
Beta / 30D Volatility Risk Regime 2.81ฮฒ ยท 101% Vol -0.01ฮฒ ยท 2% Vol Lower Realized Risk DSAC
Unified Institutional Score Composite Signal 52.7 / 100 (HOLD) 57.0 / 100 (HOLD) Higher Composite DSAC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BIOT vs DSAC Buy Guide
BIOT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BIOT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DSAC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DSAC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BIOT nor DSAC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.